Close Menu

NEW YORK – In a recent filing with the US Securities and Exchange Commission, Illumina disclosed details of its deconsolidation of Helix. According to a form 10-Q filed July 31, Illumina amended its long-term supply and license agreements with Helix, including discounted supply terms. Illumina also noted that it absorbed 50 percent of Helix's losses for the three months ended June 30.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.